Med Stock Down News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Baader Bank Aktiengesellschaft Acquires 25,379 Shares of ResMed Inc (NYSE:RMD)

Baader Bank Aktiengesellschaft grew its holdings in ResMed Inc. (NYSE:RMD – Free Report) by 1,308.2% during the fourth quarter, HoldingsChannel.com reports. The firm owned 27,319 shares of the medical equipment provider’s stock after acquiring an additional 25,379 shares during the quarter. Baader Bank Aktiengesellschaft’s holdings in ResMed were worth $4,697,000 at the end of the […]

Los angelesUnited statesMichaelj farrellResmed incNeedham companyMirae asset global investments coSecurities exchange commissionInvestment advisorsLos angeles capital managementResmed company profileRoyal bankBaader bank aktiengesellschaftVaughan david investmentsFree reportBank aktiengesellschaftAsset global investments

Mawer Investment Management Ltd Buys Shares of 22,090 ResMed Inc (NYSE:RMD)

Mawer Investment Management Ltd Buys Shares of 22,090 ResMed Inc (NYSE:RMD)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Karen drexlerMichaelj farrellNeedham companyMawer investment management ltdHsbc holdingsRoyal bankMorgan stanleySecurities exchange commissionResmed incCapital partnersCharles schwab investment management incMawer investment managementFree reportSchwab investment managementExchange commissionDirector karen drexler

ResMed Inc (NYSE:RMD) to Issue Quarterly Dividend of $0 48

ResMed Inc (NYSE:RMD) to Issue Quarterly Dividend of $0 48
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Peterc farrellResmed incRoyal bankNeedham companyGet free reportMed stock downDirector peterGeneral counsel michaelMed incRespiratory careResmed daily

Royal Bank of Canada Increases ResMed (NYSE:RMD) Price Target to $200 00

ResMed (NYSE:RMD – Free Report) had its price target raised by Royal Bank of Canada from $187.00 to $200.00 in a report issued on Friday, Benzinga reports. The firm currently has a sector perform rating on the medical equipment provider’s stock. A number of other research analysts have also recently commented on the stock. Oppenheimer […]

United kingdomGreat lakesCanada generalPeterc farrellResmed company profileBenjaminf edwards company incMv capital management incGreat lakes advisorsHarfst associates incJpmorgan chase coResmed incNeedham companyRoyal bankGulf international bank united kingdom ltdFree reportModerate buy

Insider Selling: ResMed Inc (NYSE:RMD) Director Sells 425 Shares of Stock

Insider Selling: ResMed Inc (NYSE:RMD) Director Sells 425 Shares of Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United kingdomKaren drexlerRoyal bankCambridge investment research advisors incXponance incSimplicity solutionsResmed incSecurities exchange commissionJpmorgan chase coNeedham companyGet free reportDirector karen drexlerExchange commissionMed stock downFourth swedish national pension fundInvestment research advisors